Bluetheris
Description
Bluetheris is turning cutting-edge science into game-changing innovations—revolutionizing diagnostics.
Our flagship product, Nephrovir, an in vitro medical device, enables the early detection of BK virus nephropathy, a major cause of graft loss in kidney transplant recipients.
Nephrovir combines an immunological kit with a web application that assesses the risk of BK virus nephropathy using a dedicated algorithm. This algorithm integrates the kit’s results with other clinical parameters to enhance diagnostic accuracy.
By enabling early adjustments to immunosuppressive treatment, Nephrovir helps prevent graft loss and avoid a return to dialysis.
Nephrovir has undergone two clinical trials, including a multicenter clinical study, and is currently in the CE marking process.
